Ketamine infusions for acute pain management have received substantial interest in recent years.[1][1] While studies have been encouraging, safety concerns have prompted some state professional licensing boards to issue memorandums, limiting patient access.[2][2] Despite poor bioavailability,[3][3
No takes yet. Share an insight, caveat, or question.
Lucchesi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: